{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/balanitis/management/balanitis-children/","result":{"pageContext":{"chapter":{"id":"bd1e001e-c6a9-5d54-88ca-ce4a56b46edd","slug":"balanitis-children","fullItemName":"Scenario: Balanitis - children","depth":2,"htmlHeader":"<!-- begin field 261d548a-f363-488d-bdab-2e235437539f --><h2>Scenario: Balanitis - children</h2><!-- end field 261d548a-f363-488d-bdab-2e235437539f -->","summary":"Covers the management of suspected or confirmed balanitis in boys up to 16 years of age in primary care.","htmlStringContent":"<!-- begin item eef7c1c8-0532-4acb-87f6-ec3c967bfeb3 --><!-- begin field 76a7edcd-8639-4738-bd18-acbc0157ea36 --><p>From age 1 month to 16 years (Male).</p><!-- end field 76a7edcd-8639-4738-bd18-acbc0157ea36 --><!-- end item eef7c1c8-0532-4acb-87f6-ec3c967bfeb3 -->","topic":{"id":"4da8d9db-f350-588f-83e8-f5efc3335305","topicId":"eb6c6cd9-3331-4790-a1f9-a11ed643b2b0","topicName":"Balanitis","slug":"balanitis","lastRevised":"Last revised in October 2018","chapters":[{"id":"cf843687-5035-5956-aa14-3d8bacbd404f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"41d01ca1-763c-529e-8026-28dd85d36b16","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b9dae5ef-34a6-57ed-bf21-9b9543370ecd","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2fc17559-2630-5868-aeda-16c7394d8223","slug":"changes","fullItemName":"Changes"},{"id":"699e0434-3685-5acc-9956-84bc269b6ae0","slug":"update","fullItemName":"Update"}]},{"id":"e0b4a9d5-30c1-589c-b52c-49a537ed88cf","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"045bf9d9-1913-57d7-85ac-7dd14d9a6ad1","slug":"goals","fullItemName":"Goals"},{"id":"9242a4e0-3dd3-598a-8015-c1fd35c8ae24","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8d94eba3-36ae-5c38-b3bd-c6fe5a1d1122","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9c3fec0e-6d36-590b-a67a-9fde96b588b6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dd19254a-f9ef-5cd1-af7b-f5226c2474da","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5cc7acd3-6e1c-5b23-9f58-aa1a50f67faa","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"10c99e35-8476-5d3d-a309-c80fc5ed5fa7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e615c22a-91ed-5f2c-8d1b-657c4409d5ff","slug":"definition","fullItemName":"Definition"},{"id":"93cf765a-7e94-5ba7-bc6c-d001406aa393","slug":"causes","fullItemName":"Causes"},{"id":"8f5ac951-0e46-5c89-9a50-27eb3f65076f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"feeb11e3-9d66-5d96-a507-c526af44a7f0","slug":"complications","fullItemName":"Complications"}]},{"id":"fb758dfb-b24b-5875-9570-5d6b29ad0606","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7f4b11b8-626e-56eb-9a8d-5aafbb365797","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e0d6dde7-d713-5601-94f9-9a443f7c7cb3","slug":"assessment","fullItemName":"Assessment"},{"id":"a1bd5ccf-b828-59e7-893c-ab9d9e755750","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"de355ac0-0522-5d92-a913-4694aa861fd7","fullItemName":"Management","slug":"management","subChapters":[{"id":"bd1e001e-c6a9-5d54-88ca-ce4a56b46edd","slug":"balanitis-children","fullItemName":"Scenario: Balanitis - children"},{"id":"44e5d982-e2af-5996-ab20-fcc33b89adf1","slug":"balanitis-adults","fullItemName":"Scenario: Balanitis - adults"}]},{"id":"3fdc0cf3-e98c-5a04-9525-c21e93db6dad","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"7db80726-7da5-5db6-85b2-e6a211cd3278","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"ad41f201-03ec-5da9-ac6a-1902fa6cad6c","slug":"oral-fluconazole","fullItemName":"Oral fluconazole"},{"id":"29db55e2-6292-57cc-bb96-e0331bea331b","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"41cf5c1f-073b-55f6-bca1-f483e1e31783","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"e2c0e955-b610-5ee0-83a7-020247e8d2e3","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"8384c8ca-522a-546a-971b-71a12dc40ba9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1946dc01-8848-5119-a228-39e16c9c2fee","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a80a505e-c0ca-5472-966a-cfb4d225c502","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f260f355-769f-5d83-8c42-f5b606d7cab7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bedff117-4d2b-5b3b-ae77-431100374dfe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ccf2a0ba-1a8a-5d6c-829c-a90817d3a0cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c09916ae-40e4-5285-8ce4-a0995eb5225b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fcdbbdd1-c423-5b0c-b610-1ba72cc625c9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"de355ac0-0522-5d92-a913-4694aa861fd7","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"bf7a77ce-ff16-5bae-98f6-b29acf5c1e2d","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field eac43c9b-fe99-4de8-8227-e9d1597b61d3 --><h3>Management</h3><!-- end field eac43c9b-fe99-4de8-8227-e9d1597b61d3 -->","summary":null,"htmlStringContent":"<!-- begin item 015c66ce-d0a2-404c-8769-0a82869201e2 --><!-- begin field 841cdaf1-b8e7-4310-984b-79e239c71a65 --><p><strong>If a child has <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/diagnosis/diagnosis/\">suspected balanitis</a>:</strong></p><ul><li><strong>Advise the child or parents/carers to clean the penis daily</strong> with lukewarm water and to dry it gently.<ul><li>Do not attempt to retract the foreskin to clean under it, if it is still fixed.</li><li>Do not use soap, bubble bath, or baby wipes as these may irritate the area.</li><li>Nappies should be changed frequently — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/nappy-rash/\">Nappy rash</a> for more information.</li></ul></li><li><strong>Advise on sources of written information and support,</strong> such as:<ul><li>The NHS information leaflet on <a data-hyperlink-id=\"ea9bc98e-5e22-4ffe-a4f9-a98e00b0a33d\" href=\"https://www.nhs.uk/conditions/balanitis/\" target=\"_blank\">Balanitis</a>.</li><li>The Patient.info information leaflet on <a data-hyperlink-id=\"48751d1f-fa91-4816-a6e9-a98e00b0a35a\" href=\"https://patient.info/health/balanitis-leaflet\" target=\"_blank\">Balanitis</a>.</li></ul></li><li><strong>For suspected non-specific dermatitis:</strong><ul><li>Prescribe topical hydrocortisone 1% cream or ointment once a day and an imidazole cream, the frequency depending on the preparation used, until symptoms settle or for up to 14 days.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/topical-imidazoles/\">Topical imidazoles</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li></ul></li><li><strong>For suspected irritant or allergic contact dermatitis:</strong><ul><li>Advise the person to stop any suspected triggers (such as soap, bubble bath, or creams).</li><li>Prescribe topical hydrocortisone 1% cream or ointment once a day until symptoms settle, or for up to 14 days.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li><li>Advise on the use of a regular emollient and for use as a soap substitute. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a> for more information.</li></ul></li><li><strong>For suspected or confirmed candidal balanitis:</strong><ul><li>Prescribe an imidazole cream, the frequency depending on the preparation used, until symptoms settle or for up to 14 days.<ul><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/topical-imidazoles/\">Topical imidazoles</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li><li>If inflammation is causing discomfort, consider prescribing topical hydrocortisone 1% cream or ointment for up to 14 days in addition.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li></ul></li><li><strong>For suspected or confirmed bacterial balanitis:</strong><ul><li>Prescribe oral flucloxacillin for seven days. If the person is allergic to penicillin, prescribe oral clarithromycin for seven days.<ul><li>See the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/flucloxacillin/\">Flucloxacillin</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/clarithromycin/\">Clarithromycin</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information including dosage regimens.</li></ul></li><li>If inflammation is causing discomfort, consider prescribing topical hydrocortisone 1% cream or ointment for up to 14 days in addition.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li></ul></li><li><strong>For suspected seborrhoeic dermatitis,</strong> see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a> for more information on management.</li><li><strong>If symptoms are not improving following seven days of initial treatment:</strong><ul><li>Stop treatment with topical hydrocortisone (if using).</li><li>Take a sub-preputial swab to exclude or confirm a fungal or bacterial infection, and treat accordingly. Be aware that:<ul><li>Group B streptococcus is usually a commensal and does not usually need treatment.</li><li>Candida may be a superadded infection and its presence does not exclude an underlying skin condition.</li></ul></li></ul></li><li><strong>Arrange a blood test for HbA1c to assess for underlying diabetes mellitus</strong> if balanitis is severe, persistent, or recurrent (especially if candidal balanitis is present). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for more information.</li></ul><!-- end field 841cdaf1-b8e7-4310-984b-79e239c71a65 --><!-- end item 015c66ce-d0a2-404c-8769-0a82869201e2 -->","subChapters":[{"id":"61869eb5-2a49-5333-9ed6-b28aaaec2483","slug":"basis-for-recommendation-33e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f3e6d9c5-be76-4085-8b21-9633e865ed81 --><h4>Basis for recommendation</h4><!-- end field f3e6d9c5-be76-4085-8b21-9633e865ed81 -->","summary":null,"htmlStringContent":"<!-- begin item 33e542d6-2cbd-4402-946f-7058baead0d0 --><!-- begin field 6e983a7d-057b-4b00-9356-9400f048403e --><p>The recommendations on management are largely based on the British Association of Paediatric Urologists (BAPU) publication <em>Management of foreskin conditions</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">British Association of Paediatric Urologists, 2013</a>], and have been extrapolated from expert opinion in guidelines for people aged 16 years and older in the <em>2013 European guideline for the management of balanoposthitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>] and in the Royal College of General Practitioners and British Association of Sexual Health and HIV (RCGP/BASHH) publication <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>].</p><ul><li>CKS found no evidence for the comparative effectiveness of different topical imidazole preparations for the management of balanitis.</li><li>The recommendation on the use of flucloxacillin for suspected or confirmed bacterial balanitis is pragmatic based on what CKS considers to be good clinical practice, as this antibiotic has activity against group A beta-haemolytic streptococci and <em>Staphylococcus aureus</em>. It is also based on the expert opinion of previous external reviewers of this CKS topic.</li><li>The recommendations on the significance of culture of group B streptococcus and candida following sub-preputial swabbing are extrapolated from expert opinion in the RCGP/BASHH publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>] and the European guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>].</li></ul><!-- end field 6e983a7d-057b-4b00-9356-9400f048403e --><!-- end item 33e542d6-2cbd-4402-946f-7058baead0d0 -->","subChapters":[]}]},{"id":"0bbf2c08-3af1-5d4a-8a8a-92a08b3030b7","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field d9ac514f-3b49-4e86-8397-a87101366680 --><h3>When should I refer a child?</h3><!-- end field d9ac514f-3b49-4e86-8397-a87101366680 -->","summary":null,"htmlStringContent":"<!-- begin item 37905800-01c5-4144-b78e-a8710136629a --><!-- begin field d571d7e3-5fb7-4874-9361-a87101366680 --><ul><li><strong>Arrange referral to a paediatrician, paediatric dermatologist, or paediatric urologist or surgeon,</strong> depending on the most likely underlying cause and clinical judgement, if:<ul><li>The diagnosis is uncertain.</li><li>There is persistent or recurrent balanitis which is not responding to management in primary care — circumcision may be considered.</li><li>There is suspected <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/background-information/causes/\">lichen sclerosus</a> and/or persistent phimosis — refer to a paediatric urologist or surgeon for consideration of circumcision.</li></ul></li></ul><!-- end field d571d7e3-5fb7-4874-9361-a87101366680 --><!-- end item 37905800-01c5-4144-b78e-a8710136629a -->","subChapters":[{"id":"dc4dcde1-56e8-58b8-8f52-e44ddebecb79","slug":"basis-for-recommendation-c27","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ace56cfe-50a1-4318-8d2d-a87101366693 --><h4>Basis for recommendation</h4><!-- end field ace56cfe-50a1-4318-8d2d-a87101366693 -->","summary":null,"htmlStringContent":"<!-- begin item c270d977-c74a-4f34-a75a-a87101366693 --><!-- begin field d7940882-fa9c-4086-a21e-a87101366693 --><p>The recommendations on referral are largely based on expert opinion in the British Association of Paediatric Urologists (BAPU) publication <em>Management of foreskin conditions</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">British Association of Paediatric Urologists, 2013</a>], and are extrapolated from expert opinion in the <em>2013 European guideline for the management of balanoposthitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>]. They are also based on expert opinion in a review article on benign paediatric penile skin conditions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Castagnetti, 2015</a>].</p><ul><li>Persistent balanitis which does not respond to optimal treatment in primary care and with no evidence of an underlying infective cause after sub-preputial swabs may benefit from surgical assessment, as circumcision in these cases can be curative [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>].</li><li>The BAPU publication states that the medical indications for circumcision include balanitis xerotica obliterans and severe, recurrent attacks of balanitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">British Association of Paediatric Urologists, 2013</a>].</li></ul><!-- end field d7940882-fa9c-4086-a21e-a87101366693 --><!-- end item c270d977-c74a-4f34-a75a-a87101366693 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}